We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.45B
AUM Growth
+$44.4M
Cap. Flow
-$94.4M
Cap. Flow %
-3.85%
Top 10 Hldgs %
40.67%
Holding
310
New
32
Increased
52
Reduced
85
Closed
39

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$20.8M
2
CL icon
Colgate-Palmolive
CL
+$20.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$20M
4
AMAT icon
Applied Materials
AMAT
+$19.4M
5
NFLX icon
Netflix
NFLX
+$19.1M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.4M
2
LVS icon
Las Vegas Sands
LVS
+$21.8M
3
META icon
Meta Platforms (Facebook)
META
+$21.8M
4
XOM icon
ExxonMobil
XOM
+$18.7M
5
NOW icon
ServiceNow
NOW
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 35.89%
2 Healthcare 15.81%
3 Industrials 10.04%
4 Consumer Discretionary 8.44%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUM
126
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$4.48M 0.18%
122,498
-1,050
-0.8% -$41.2K
ENSG icon
127
The Ensign Group
ENSG
$10.6B
$4.48M 0.18%
+36,230
New +$4.32M
GVA icon
128
Granite Construction
GVA
$5.16B
$4.45M 0.18%
71,850
-730
-1% -$43.2K
PAA icon
129
Plains All American Pipeline
PAA
$17.6B
$4.41M 0.18%
247,109
-53,500
-18% -$934K
SITM icon
130
SiTime
SITM
$13.8B
$4.39M 0.18%
+35,280
New +$3.76M
UTZ icon
131
Utz Brands
UTZ
$1.24B
$4.28M 0.17%
+257,170
New +$4.63M
BPMC
132
DELISTED
Blueprint Medicines
BPMC
$4.25M 0.17%
+39,440
New +$3.95M
WD icon
133
Walker & Dunlop
WD
$1.73B
$4.14M 0.17%
42,160
-360
-0.8% -$34.3K
CSTM icon
134
Constellium
CSTM
$3.76B
$4.13M 0.17%
219,200
-1,880
-0.9% -$39.1K
CRDO icon
135
Credo Technology Group
CRDO
$33.1B
$4.04M 0.16%
126,430
-56,480
-31% -$1.25M
PPC icon
136
Pilgrim's Pride
PPC
$7.13B
$3.99M 0.16%
103,780
-46,770
-31% -$1.69M
AVAV icon
137
AeroVironment
AVAV
$7.19B
$3.97M 0.16%
21,780
-11,030
-34% -$1.98M
SWTX
138
DELISTED
SpringWorks Therapeutics
SWTX
$3.96M 0.16%
105,160
+26,810
+34% +$1.13M
WWD icon
139
Woodward
WWD
$23B
$3.92M 0.16%
22,470
-5,840
-21% -$994K
VMI icon
140
Valmont Industries
VMI
$8.86B
$3.79M 0.15%
+13,810
New +$3.37M
NEOG icon
141
Neogen
NEOG
$2.05B
$3.69M 0.15%
+236,330
New +$3.29M
ITCI
142
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.68M 0.15%
53,780
-450
-0.8% -$31.2K
OXY icon
143
Occidental Petroleum
OXY
$55.7B
$3.63M 0.15%
57,615
– –
FANG icon
144
Diamondback Energy
FANG
$56B
$3.63M 0.15%
18,135
– –
KFY icon
145
Korn Ferry
KFY
$4.31B
$3.59M 0.15%
+53,460
New +$3.44M
DFIN icon
146
Donnelley Financial Solutions
DFIN
$1.28B
$3.46M 0.14%
58,080
-570
-1% -$34.8K
GNTX icon
147
Gentex
GNTX
$5.1B
$3.39M 0.14%
100,420
-5,860
-6% -$202K
PCVX icon
148
Vaxcyte
PCVX
$7.65B
$3.3M 0.13%
43,690
-31,350
-42% -$2.13M
SKY icon
149
Champion Homes
SKY
$4.41B
$3.14M 0.13%
46,300
-28,580
-38% -$2.14M
SG icon
150
Sweetgreen
SG
$756M
$3.11M 0.13%
+103,220
New +$2.83M
4 5
6
7 8

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JIC
Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return

Castleark Management's Q2 2024 Portfolio in Review

As of Q2 2024, Castleark Management held 310 positions worth $2.45B, up 1.8% from $2.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Castleark Management withdrew a net $94.4M in Q2 2024, closing 39 positions and reducing 85 holdings. Its most notable exit was Las Vegas Sands, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Castleark Management opened a new position in Colgate-Palmolive worth $21.5M.

  • Castleark Management's largest Q2 2024 buy was Colgate-Palmolive: 221,053 shares worth $21.5M.
  • Castleark Management added most to Union Pacific in Q2 2024, an estimated $20.8M increase.
  • Castleark Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $29.4M.
  • Castleark Management fully exited Las Vegas Sands in Q2 2024, selling an estimated $21.8M.
  • Castleark Management's ten largest holdings make up 41% of its $2.45B portfolio in Q2 2024.
  • Castleark Management opened 32 new positions and closed 39 in Q2 2024.
  • Castleark Management's portfolio value rose 1.8% quarter-over-quarter to $2.45B.

Based on Castleark Management's 13F filing for Q2 2024, filed 14 Aug 2024.